Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on June 3, 2025
Fortrea to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
DURHAM, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Interim Chief Executive Officer, Peter M. Neupert and Chief Financial Officer, Jill McConnell …
Bluejay Diagnostics Provides Mid-Year Business and Corporate Update
GlobeNewswire
·
June 3, 2025
ACTON, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid near-patient testing solutions for critical care, today provided a 2025 mid-year business …
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
GlobeNewswire
·
June 3, 2025
MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the European launch of OviTex Inguinal …
Merus N.V. Announces Proposed Public Offering of Common Shares
GlobeNewswire
·
June 3, 2025
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug …
Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
GlobeNewswire
·
June 3, 2025
Best-in-disease profile with JAK-like efficacy and monthly (Q4W) dosing in both three-month placebo-controlled and six-month blinded treatment period Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max …
InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer
GlobeNewswire
·
June 3, 2025
MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced the appointment of Michael Lawless, an …
Windtree Announces Plan for Cryptocurrency Treasury Policy
GlobeNewswire
·
June 3, 2025
WARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …
Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that members of …
HealthEquity Reports First Quarter Ended April 30, 2025 Financial Results
GlobeNewswire
·
June 3, 2025
Highlights of the first quarter include: Revenue of $330.8 million, an increase of 15% compared to $287.6 million in Q1 FY25. Net income of $53.9 million, an increase of 87% compared to $28.8 million in Q1 FY25, with non-GAAP net income of $85.8 million, …
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
VANCOUVER, British Columbia and BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
Immix Biopharma Announces Primary Endpoint Met in positive NXC-201 Interim Results Presented at ASCO, Enabling Path to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
GlobeNewswire
·
June 3, 2025
Immix Biopharma today presented results at ASCO from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201, meeting its primary endpoint. – NXC-201 met primary endpoint with a complete response (CR) rate of 70% (7/10 patients) – – No …
Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book
GlobeNewswire
·
June 3, 2025
Biofrontera received patent approval for the revised formulation of Ameluz® in April 2025, extending patent protection through to December 2043. The Orange Book is published by the U.S. Food and Drug Administration (FDA) and lists all approved prescription …
Epigenetics Market Anticipated to Achieve 11.8% CAGR
GlobeNewswire
·
June 3, 2025
Boston, June 03, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Epigenetics Markets” is projected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029 at a compound annual growth rate (CAGR) of 11.8% …
Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics | DelveInsight
GlobeNewswire
·
June 3, 2025
New York, USA, June 03, 2025 (GLOBE NEWSWIRE) -- Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics | DelveInsight The Huntington's disease treatment market is poised …
Vetcon HVAC & Plumbing of Orlando Expands Expert Retrofit Services for Hotels and Hospitals throughout Orange County, FL
EIN Presswire
·
June 3, 2025
Providing Advanced HVAC Retrofit Solutions for Demanding Environments ORLANDO, FL, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Vetcon HVAC …
RESTEM to Present at the 2025 BIO International Convention
GlobeNewswire
·
June 3, 2025
MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that Andres Isaias, its Chief Executive Officer, …
Dipen Parekh, M.D. named Chief Executive Officer of the University of Miami Health System
GlobeNewswire
·
June 3, 2025
CORAL GABLES, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- The University of Miami Board of Trustees has unanimously selected Dr. Dipen J. Parekh as the next Chief Executive Officer of UHealth, as well as Executive Vice President for Health Affairs at the …
Sutter Health Receives Historic $110 Million Gift to Expand Access, Advance Care, and Elevate Patient Experience Across Northern California
GlobeNewswire
·
June 3, 2025
Northern California, June 03, 2025 (GLOBE NEWSWIRE) -- Sutter Health today announced an unprecedented $110 million philanthropic gift from a long-standing anonymous donor — the largest in the not-for-profit health system’s history. This historic donation …
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 3, 2025
Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ≥5 years CARTITUDE-4 subgroup analyses featured in a …
Vital Wound Care Launches AI-Driven Wound App and Expands In-Home Services Across Greater Houston
GlobeNewswire
·
June 3, 2025
New AI-powered app and biologic wound therapies bring hospital-grade care to homes across Greater Houston. Image by Vital Wound Care HOUSTON, June 03, 2025 (GLOBE NEWSWIRE) -- On May 1, Vital Wound Care introduced a free, web-based Wound Assessment App as …